Medical Xpress April 10, 2023
Hundreds of pharmaceutical executives on Monday condemned a US judicial ruling outlawing a leading abortion pill, saying it threatens the development of needed medications in the United States.
Some 400 executives, including Pfizer CEO Albert Bourla and top management at Novartis, Biogen and Merck, signed a letter criticizing Friday’s ruling by Texas federal judge Matthew Kacsmaryk that could block access to mifepristone nationwide.
“The decision ignores decades of scientific evidence and legal precedent,” said the letter slamming Kacsmaryk’s move to bar the drug 23 years after it was approved by the US Food and Drug Administration (FDA).
“Judge Kacsmaryk’s act of judicial interference has set a precedent for diminishing FDA’s authority over drug approvals, and in so doing, creates uncertainty...
Today's Sponsors
Today's Sponsor